Thailand Pushed To Deny Foreign Patents For Flu Drugs From Thai Herbs
This article was originally published in PharmAsia News
Executive SummaryThailand's Intellectual Property Department is being pressured by a biodiversity group to avoid granting foreign companies patents for flu drugs made from the nation's herbal plants. At issue is the fah talai jon plant used by practitioners of traditional medicine to treat sore throat and diarrhea symptoms of the flu. The Biothai organization said that granting a patent on the chemical extract of the plant should be avoided. The IPD said it has received several applications from foreign companies to patent certain developments involving the nation's herbal plants. (Click here for more
You may also be interested in...
The $9.7bn acquisition hinges on the small interfering RNA inclisiran, but an ongoing cardiovascular outcomes trial, manufacturing hurdles, and reimbursement challenges provide subjects for concern.
US congressional leaders and medtech industry advocacy group AdvaMed are giving their full-throated endorsement to a US-Mexico-Canada (USMCA) trade agreement announced by the US Trade Representative's Office on 10 December. See what AdvaMed's president and CEO, Scott Whitaker, said about it in a statement here.
FDA seems poised to approve the drug for the orphan eye disease called TED, but remains concerned about labeling for some adverse events.